REPORT ID 705

Asia-Pacific Drug-Eluting Balloons Market Report 2017

Publish Date
01-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the Asia-Pacific Drug-Eluting Balloons market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Drug-Eluting Balloons for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Drug-Eluting Balloons market competition by top manufacturers/players, with Drug-Eluting Balloons sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Boston Scientific
    Medtronic
    Cook Medical
    C.R. Bard
    B. Braun
    Eurocor GmbH
    Blue Medical
    Bayer
    Aachen Resonance
    Acrostak

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Semi-Compliant Balloons
    Non-Compliant Balloons

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Treatment of In-stent Restenosis (ISR)
    Treatment of Small Vessel Disease (SVD)
    Treatment of Bifurcation Stenoses
    Treatment of Primary Coronary Artery Disease

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Drug-Eluting Balloons Market Report 2017
1 Drug-Eluting Balloons Overview
    1.1 Product Overview and Scope of Drug-Eluting Balloons
    1.2 Classification of Drug-Eluting Balloons by Product Category
        1.2.1 Asia-Pacific Drug-Eluting Balloons Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Drug-Eluting Balloons Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Semi-Compliant Balloons
        1.2.4 Non-Compliant Balloons
    1.3 Asia-Pacific Drug-Eluting Balloons Market by Application/End Users
        1.3.1 Asia-Pacific Drug-Eluting Balloons Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Treatment of In-stent Restenosis (ISR)
        1.3.3 Treatment of Small Vessel Disease (SVD)
        1.3.4 Treatment of Bifurcation Stenoses
        1.3.5 Treatment of Primary Coronary Artery Disease
    1.4 Asia-Pacific Drug-Eluting Balloons Market by Region
        1.4.1 Asia-Pacific Drug-Eluting Balloons Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Drug-Eluting Balloons (2012-2022)
        1.5.1 Asia-Pacific Drug-Eluting Balloons Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Drug-Eluting Balloons Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Drug-Eluting Balloons Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Drug-Eluting Balloons Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Drug-Eluting Balloons Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Drug-Eluting Balloons Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Drug-Eluting Balloons (Volume and Value) by Type
        2.2.1 Asia-Pacific Drug-Eluting Balloons Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Drug-Eluting Balloons Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Drug-Eluting Balloons (Volume) by Application
    2.4 Asia-Pacific Drug-Eluting Balloons (Volume and Value) by Region
        2.4.1 Asia-Pacific Drug-Eluting Balloons Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Drug-Eluting Balloons Revenue and Market Share by Region (2012-2017)

3 China Drug-Eluting Balloons (Volume, Value and Sales Price)
    3.1 China Drug-Eluting Balloons Sales and Value (2012-2017)
        3.1.1 China Drug-Eluting Balloons Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Drug-Eluting Balloons Revenue and Growth Rate (2012-2017)
        3.1.3 China Drug-Eluting Balloons Sales Price Trend (2012-2017)
    3.2 China Drug-Eluting Balloons Sales Volume and Market Share by Type
    3.3 China Drug-Eluting Balloons Sales Volume and Market Share by Application

4 Japan Drug-Eluting Balloons (Volume, Value and Sales Price)
    4.1 Japan Drug-Eluting Balloons Sales and Value (2012-2017)
        4.1.1 Japan Drug-Eluting Balloons Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Drug-Eluting Balloons Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Drug-Eluting Balloons Sales Price Trend (2012-2017)
    4.2 Japan Drug-Eluting Balloons Sales Volume and Market Share by Type
    4.3 Japan Drug-Eluting Balloons Sales Volume and Market Share by Application

5 South Korea Drug-Eluting Balloons (Volume, Value and Sales Price)
    5.1 South Korea Drug-Eluting Balloons Sales and Value (2012-2017)
        5.1.1 South Korea Drug-Eluting Balloons Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Drug-Eluting Balloons Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Drug-Eluting Balloons Sales Price Trend (2012-2017)
    5.2 South Korea Drug-Eluting Balloons Sales Volume and Market Share by Type
    5.3 South Korea Drug-Eluting Balloons Sales Volume and Market Share by Application

6 Taiwan Drug-Eluting Balloons (Volume, Value and Sales Price)
    6.1 Taiwan Drug-Eluting Balloons Sales and Value (2012-2017)
        6.1.1 Taiwan Drug-Eluting Balloons Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Drug-Eluting Balloons Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Drug-Eluting Balloons Sales Price Trend (2012-2017)
    6.2 Taiwan Drug-Eluting Balloons Sales Volume and Market Share by Type
    6.3 Taiwan Drug-Eluting Balloons Sales Volume and Market Share by Application

7 India Drug-Eluting Balloons (Volume, Value and Sales Price)
    7.1 India Drug-Eluting Balloons Sales and Value (2012-2017)
        7.1.1 India Drug-Eluting Balloons Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Drug-Eluting Balloons Revenue and Growth Rate (2012-2017)
        7.1.3 India Drug-Eluting Balloons Sales Price Trend (2012-2017)
    7.2 India Drug-Eluting Balloons Sales Volume and Market Share by Type
    7.3 India Drug-Eluting Balloons Sales Volume and Market Share by Application

8 Southeast Asia Drug-Eluting Balloons (Volume, Value and Sales Price)
    8.1 Southeast Asia Drug-Eluting Balloons Sales and Value (2012-2017)
        8.1.1 Southeast Asia Drug-Eluting Balloons Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Drug-Eluting Balloons Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Drug-Eluting Balloons Sales Price Trend (2012-2017)
    8.2 Southeast Asia Drug-Eluting Balloons Sales Volume and Market Share by Type
    8.3 Southeast Asia Drug-Eluting Balloons Sales Volume and Market Share by Application

9 Australia Drug-Eluting Balloons (Volume, Value and Sales Price)
    9.1 Australia Drug-Eluting Balloons Sales and Value (2012-2017)
        9.1.1 Australia Drug-Eluting Balloons Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Drug-Eluting Balloons Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Drug-Eluting Balloons Sales Price Trend (2012-2017)
    9.2 Australia Drug-Eluting Balloons Sales Volume and Market Share by Type
    9.3 Australia Drug-Eluting Balloons Sales Volume and Market Share by Application

10 Asia-Pacific Drug-Eluting Balloons Players/Suppliers Profiles and Sales Data
    10.1 Boston Scientific
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Boston Scientific Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Medtronic
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Medtronic Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Cook Medical
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Cook Medical Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 C.R. Bard
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 C.R. Bard Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 B. Braun
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 B. Braun Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Eurocor GmbH
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Eurocor GmbH Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Blue Medical
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Blue Medical Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Bayer
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Bayer Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Aachen Resonance
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Aachen Resonance Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Acrostak
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Drug-Eluting Balloons Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Acrostak Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview

11 Drug-Eluting Balloons Manufacturing Cost Analysis
    11.1 Drug-Eluting Balloons Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Drug-Eluting Balloons

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Drug-Eluting Balloons Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Drug-Eluting Balloons Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Drug-Eluting Balloons Market Forecast (2017-2022)
    15.1 Asia-Pacific Drug-Eluting Balloons Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Drug-Eluting Balloons Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Drug-Eluting Balloons Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Drug-Eluting Balloons Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Drug-Eluting Balloons Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Drug-Eluting Balloons Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Drug-Eluting Balloons Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Drug-Eluting Balloons Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Drug-Eluting Balloons Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Drug-Eluting Balloons Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Drug-Eluting Balloons Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Drug-Eluting Balloons Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Drug-Eluting Balloons Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Drug-Eluting Balloons Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Drug-Eluting Balloons Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Drug-Eluting Balloons Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Drug-Eluting Balloons Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Drug-Eluting Balloons Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Drug-Eluting Balloons Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer